Volume 4 - Issue 10 - October 2004
Department
EP 101
05/01/2008
Two new questions are presented for discussion in this month's discussion group.
Two new questions are presented for discussion in this month's discussion group.
Two new questions are presented...
05/01/2008
EP Lab Digest
Column
Feature Interview
05/01/2008
The current pharmacological options available to treat patients with AF are often directed at antithrombotic therapy and efforts to optimally control the ventricular response. With particular reference to individuals who would benefit from...
The current pharmacological options available to treat patients with AF are often directed at antithrombotic therapy and efforts to optimally control the ventricular response. With particular reference to individuals who would benefit from...
The current pharmacological...
05/01/2008
EP Lab Digest
Feature Interview
05/01/2008
The HeartStart Home Defibrillator received FDA clearance in November 2002. This was for prescription-use only. It was the first of a new generation of defibrillators specifically designed for home use.
The HeartStart Home Defibrillator received FDA clearance in November 2002. This was for prescription-use only. It was the first of a new generation of defibrillators specifically designed for home use.
The HeartStart Home...
05/01/2008
EP Lab Digest
Spotlight Interview
05/01/2008
With 56 members of the MGH Cardiac Arrhythmia Service staff, we pride ourselves in a 26-year history of providing the highest quality and most advanced care to patients with cardiac arrhythmias.
With 56 members of the MGH Cardiac Arrhythmia Service staff, we pride ourselves in a 26-year history of providing the highest quality and most advanced care to patients with cardiac arrhythmias.
With 56 members of the MGH...
05/01/2008
EP Lab Digest
Feature
Review
05/01/2008
I have the difficult task to talk about t-wave alternans on a cellular level to a crew of clinical electrophysiologists. I will try to make it simple.
I have the difficult task to talk about t-wave alternans on a cellular level to a crew of clinical electrophysiologists. I will try to make it simple.
I have the difficult task to...
05/01/2008
EP Lab Digest
Review
05/01/2008
Hypertrophic cardiomyopathy is the most common genetically-associated form of sudden cardiac death. It is estimated that 1 in 500 people (0.2% of the general population) carry an HCM genetic mutation.
Hypertrophic cardiomyopathy is the most common genetically-associated form of sudden cardiac death. It is estimated that 1 in 500 people (0.2% of the general population) carry an HCM genetic mutation.
Hypertrophic cardiomyopathy is...
05/01/2008
EP Lab Digest
Perspectives
05/01/2008
The preponderance of evidence from published clinical studies of right atrial catheter ablation strongly suggests that this procedure is safe and effective for the management of drug-refractory patients with paroxysmal AF.
The preponderance of evidence from published clinical studies of right atrial catheter ablation strongly suggests that this procedure is safe and effective for the management of drug-refractory patients with paroxysmal AF.
The preponderance of evidence...
05/01/2008
EP Lab Digest
